ALCEDIAG
biomarkers for better health

ALCEDIAG develops innovative solutions for medical diagnosis. The first tests developed concerned psychiatric illnesses. They rely on biomarkers used to evaluate the neurotoxicity of drugs under development and in patients to improve diagnosis and patient management.